Cargando…

Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma

Cholestatic liver injury is characterized by damage induced on the biliary tree and cholangiocytes, the cells lining the biliary tree, thus they are termed “cholangiopathies”. Cholangiopathies include diseases such as Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Biliary Atresia and C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virani, Shohaib, Akers, Austin, Stephenson, Kristen, Smith, Steven, Kennedy, Lindsey, Alpini, Gianfranco, Francis, Heather
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319937/ https://www.ncbi.nlm.nih.gov/pubmed/30613437 http://dx.doi.org/10.4172/2167-0889.1000231

Ejemplares similares

Cellular crosstalk during cholestatic liver injury
por: Thomson, Joanne, et al.
Publicado: (2017)

Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling
por: Kennedy, Lindsey, et al.
Publicado: (2020)

Current Advances in Basic and Translational Research of Cholangiocarcinoma
por: Sato, Keisaku, et al.
Publicado: (2021)

Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice
por: Kennedy, Lindsey, et al.
Publicado: (2016)

Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Prolonged Administration of Melatonin Ameliorates Liver Phenotypes in Cholestatic Murine Model
por: Ceci, Ludovica, et al.
Publicado: (2022)

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases
por: Meadows, Vik, et al.
Publicado: (2020)

Neuroendocrine Changes in Cholangiocarcinoma Growth
por: Sato, Keisaku, et al.
Publicado: (2020)

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
por: Ceci, Ludovica, et al.
Publicado: (2022)

Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes
por: Wan, Ying, et al.
Publicado: (2019)

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Cholestatic Liver Injury in a Patient with Tertiary Syphilis
por: Mujumdar, Sahaj, et al.
Publicado: (2022)

Intercellular Communication between Hepatic Cells in Liver Diseases
por: Sato, Keisaku, et al.
Publicado: (2019)

Dataset on transcriptomic profiling of cholestatic liver injury in an in vitro and in vivo animal model
por: Gijbels, Eva, et al.
Publicado: (2020)

Isolation and characterization of hepatic mast cells from cholestatic rats
por: Hargrove, Laura, et al.
Publicado: (2016)

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Chronic Cholestatic Liver Injury Attributable to Vedolizumab
por: Stine, Jonathan G., et al.
Publicado: (2016)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Biliary Epithelial Senescence in Liver Disease: There Will Be SASP
por: Meadows, Vik, et al.
Publicado: (2021)

Protective Effects of Guava Pulp on Cholestatic Liver Injury
por: Peng, Jian, et al.
Publicado: (2013)

Dabigatran etexilate: Cholestatic liver injury: case report
Publicado: (2021)

Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient
por: Gijbels, Eva, et al.
Publicado: (2021)

Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis
por: Sato, Keisaku, et al.
Publicado: (2022)

Recent Advances in Understanding Cholangiocarcinoma
por: Kennedy, Lindsey, et al.
Publicado: (2017)

PPARα activation protects against cholestatic liver injury
por: Zhao, Qi, et al.
Publicado: (2017)

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019)

A rare case of cefepime-induced cholestatic liver injury
por: Liao, Pei-Fei, et al.
Publicado: (2019)

Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury
por: Gao, Xingjuan, et al.
Publicado: (2020)

Severe Cholestatic Drug-Induced Liver Injury With Cephalosporin Use
por: Yang, Kevin, et al.
Publicado: (2022)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis
por: Owen, Travis, et al.
Publicado: (2023)

The functional role of microRNAs in alcoholic liver injury
por: McDaniel, Kelly, et al.
Publicado: (2014)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
por: Zhou, Tianhao, et al.
Publicado: (2021)

Maternal obesogenic diet enhances cholestatic liver disease in offspring
por: Thompson, Michael D., et al.
Publicado: (2022)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
por: Min, Jianbin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cs24sv4l1r36lhrf390qlf3mgu